Document is current
Any future updates will be listed below
-
Authors
Di Timoteo, Gaia https://orcid.org/0000-0003-4516-9945
Giuliani, Andrea https://orcid.org/0009-0002-2327-3792
Setti, Adriano
Biagi, Martina C. https://orcid.org/0009-0002-4597-9796
Lisi, Michela https://orcid.org/0000-0003-0360-4777
Santini, Tiziana
Grandioso, Alessia
Mariani, Davide https://orcid.org/0000-0003-0903-5632
Castagnetti, Francesco https://orcid.org/0000-0001-8681-634X
Perego, Eleonora https://orcid.org/0000-0002-1700-584X
Zappone, Sabrina https://orcid.org/0000-0003-2695-4999
Lattante, Serena
Sabatelli, Mario
Rotili, Dante
Vicidomini, Giuseppe https://orcid.org/0000-0002-3085-730X
Bozzoni, Irene https://orcid.org/0000-0002-3485-8537
- License Information
-
More Information
Article History
Received: 4 October 2023
Accepted: 30 May 2024
First Online: 12 June 2024
Competing interests
: Sapienza University of Rome, Fondazione Istituto Italiano di Tecnologia (IIT) are currently in the process of a patent application. Patent applicant: Sapienza University of Rome, Fondazione Istituto Italiano di Tecnologia (IIT) name of inventors: Irene Bozzoni, Gaia Di Timoteo, Andrea Giuliani, Adriano Setti application number: IT102023000022302 status of application: pending specific aspect of manuscript covered in patent application: use of METTL3 inhibitors in the treatment of protein aggregation diseases. The remaining authors declared no competing interests.
